Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Total Debt / Capital

Amag Pharmaceuticals Total Debt / Capital Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Total Debt / Capital from 2014 to 2020.
  • Amag Pharmaceuticals Total Debt / Capital for the quarter ending June 06, 2020 was $55m a 33.31% increase of 18m year over year
  • Amag Pharmaceuticals Total Debt / Capital for the last 12 months ending June 06, 2020 was $55m a 33.31% increase of 18m year over year
  • Amag Pharmaceuticals Annual Total Debt / Capital for 2019 was $52m a 46.66% increase of 24m from 2018
  • Amag Pharmaceuticals Annual Total Debt / Capital for 2018 was $28m a -74.33% decrease of -21m from 2017
  • Amag Pharmaceuticals Annual Total Debt / Capital for 2017 was $48m a -6.60% decrease of -3m from 2016
Other Ratios Metrics:
  • Amag Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $1m a -3,223.97% decrease of -46m year over year
  • Amag Pharmaceuticals Total Debt / Equity for the quarter ending September 09, 2018 was $37m a -153.66% decrease of -56m year over year
View Chart On Koyfin

Quarterly AMAG Total Debt / Capital Data

06/2020$55m
03/2020$54m
12/2019$52m
09/2019$37m
06/2019$36m
03/2019$31m
12/2018$28m
09/2018$27m
06/2018$51m
03/2018$50m

Annual AMAG Total Debt / Capital Data

2019$52m
2018$28m
2017$48m
2016$51m
2015$52m
2014$52m